You are here

Home

Clinical Trials: Central Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, February 21, 2020 - 12:00
Alogenic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke
Conditions:   Ischemic Stroke;   Adipose Tissue-derived Stem Cell;   Functional Status
Interventions:   Other: Alogenic adipose tissue-derived stem cells;   Drug: Placebo solution
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Not yet recruiting
Posted: Thursday, February 20, 2020 - 12:00
BCI-FES Therapy for Stroke Rehabilitation
Conditions:   Ischemic Stroke;   Hemorrhagic Stroke
Interventions:   Device: BCI-FES dorsiflexion therapy;   Behavioral: Physiotherapy one hour;   Behavioral: Physiotherapy two hours
Sponsor:   University of California, Irvine
Recruiting
Posted: Tuesday, February 18, 2020 - 12:00
Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy
Condition:   Cerebral Palsy
Intervention:   Drug: Amantadine Hydrochloride
Sponsor:   Columbia University
Recruiting
Posted: Friday, February 7, 2020 - 12:00
The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy
Condition:   Hypoxia-Ischemia, Brain
Intervention:   Biological: CL2020 cells
Sponsors:   Nagoya University;   Life Science Institute, Inc.
Not yet recruiting
Posted: Monday, January 13, 2020 - 12:00
Intranasal Human Milk for Intraventricular Hemorrhage
Condition:   Intraventricular Hemorrhage
Intervention:   Other: Human breast milk
Sponsors:   The Hospital for Sick Children;   MOUNT SINAI HOSPITAL
Not yet recruiting
Posted: Tuesday, January 7, 2020 - 12:00
RAPA-501 Therapy for ALS
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: RAPA-501 Autologous T cells
Sponsors:   Rapa Therapeutics LLC;   Massachusetts General Hospital;   Hackensack Meridian Health
Not yet recruiting
Posted: Tuesday, January 7, 2020 - 12:00
Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients.
Condition:   Huntington Disease
Intervention:   Biological: Cellavita-HD
Sponsors:   Azidus Brasil;   Cellavita Pesquisa Científica Ltda
Not yet recruiting
Posted: Thursday, December 19, 2019 - 12:00
Safety Stem Cells in Spinal Cord Injury
Condition:   Spinal Cord Injuries
Intervention:   Biological: Neuro-Cells
Sponsor:   Neuroplast
Not yet recruiting
Posted: Wednesday, December 18, 2019 - 12:00
Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias
Conditions:   Refractory Depression;   Anxiety Disorders;   Neurodegenerative Diseases
Intervention:   Other: Exosomes
Sponsor:   Neurological Associates of West Los Angeles
Recruiting
Posted: Wednesday, October 23, 2019 - 12:00
Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury
Conditions:   Spinal Cord Injuries;   Tendinopathy;   Rotator Cuff Tears;   Shoulder Pain
Interventions:   Device: Lipogems;   Drug: Dexamethasone
Sponsor:   Kessler Foundation
Recruiting

Pages